Qube Research & Technologies (QRT)
ALXN

Qube Research & Technologies (QRT)’s Alexion Pharmaceuticals ALXN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-117,649
Closed -$21.6M – 3043
2021
Q2 		$21.6M Buy
117,649
+56,167
+91% +$9.64M 0.27% 79
2021
Q1 		$9.4M Buy
61,482
+24,318
+65% +$3.76M 0.16% 146
2020
Q4 		$5.81M Buy
+37,164
New +$4.78M 0.09% 273
2020
Q3 		– Sell
-78,957
Closed -$8.86M – 2262
2020
Q2 		$8.86M Buy
78,957
+60,089
+318% +$6.38M 0.13% 196
2020
Q1 		$1.69M Sell
18,868
-28,490
-60% -$2.8M 0.08% 261
2019
Q4 		$5.12M Buy
47,358
+37,362
+374% +$4M 0.16% 121
2019
Q3 		$979K Buy
+9,996
New +$1.13M 0.65% 31
2019
Q2 		– Sell
-4,877
Closed -$659K – 597
2019
Q1 		$659K Buy
4,877
+1,466
+43% +$182K 0.09% 290
2018
Q4 		$332K Sell
3,411
-2,376
-41% -$281K 0.19% 181
2018
Q3 		$804K Buy
+5,787
New +$726K 0.11% 148
2018
Q2 		– Sell
-1,138
Closed -$126K – 946
2018
Q1 		$126K Buy
+1,138
New +$136K 0.05% 207

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return